Novartis Heart-Failure Treatment to Get Speedy EU Review

Novartis said an important new drug for treating heart failure has been granted an accelerated review by European authorities, improving its chances of approval in Europe next year.



from WSJ.com: US Business http://ift.tt/1xZ2JeE

via IFTTT